Denemek ALTIN - Özgür
Tim Cook's 'long arc of time' prepared Apple for the trade war
Mint Hyderabad
|April 14, 2025
Cook worked to forge personal relationships with US President Donald Trump and his inner circle
Tim Cook and his adherence to the "long arc of time" won—again.
The iPhone is exempt from the White House's latest escalation of the trade war with China, the Trump administration quietly announced late Friday.
The disclosure came after more than a week of existential dread. At one point, Apple had lost almost $800 billion of market value after Trump officials claimed imposing sky-high tariffs on Chinese-made goods would shift iPhone assembly to American factories.
look really, really bad for Apple.
Cook, who rose to CEO from supply-chain whiz, became one of the highest-profile examples of a U.S. corporate leader trying to navigate an escalating trade war that threatened to jack-up the cost of iPhones, cut into the company's lofty profit margins and undo his legacy as the executive most credited with the tech giant's China manufacturing strategy.
Apple never publicly addressed the latest tariff dilemma—though it was clear that Cook was taking behind-the-scenes actions to try to mitigate the fallout. The company rushed India-made iPhones to the U.S., and Cook no doubt lobbied Trump for an exemption from the China tariffs that had soared past 100% in recent days.
Instead, President Trump blinked—again.
The two men seem to be playing a different game. Trump was forced to backpedal by the quickly eroding stock and bond markets—his go-to measure of public support. Meanwhile, Cook looked toward the "long arc of time"—his go-to guide in a world where investors and customers constantly agitate for what's coming next for Apple, have little patience and judge the chief executive on a quarterly basis.
That doesn't mean that for a brief moment things didn't
Yet those in the Trump administration expecting Apple to simply shift iPhone assembly to the U.S. haven't been following how Cook has operated as CEO the past 13 years.
Bu hikaye Mint Hyderabad dergisinin April 14, 2025 baskısından alınmıştır.
Binlerce özenle seçilmiş premium hikayeye ve 9.000'den fazla dergi ve gazeteye erişmek için Magzter GOLD'a abone olun.
Zaten abone misiniz? Oturum aç
Mint Hyderabad'den DAHA FAZLA HİKAYE
Mint Hyderabad
Nvidia, Eli Lilly to invest $1 bn in AI lab
Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence (AI) in the pharmaceutical industry.
1 min
January 13, 2026
Mint Hyderabad
Shadowfax IPO to open next week
Logistics services provider Shadowfax is set to launch its ₹1,900-crore initial public offering (IPO) next week, targeting a valuation of ₹7,400 crore, people familiar with the matter said on Monday.
1 min
January 13, 2026
Mint Hyderabad
The US climate cop-out should galvanize others
America's withdrawal from the global battle against climate change is a signal for the rest of the world to unite for the greater good. The cause is vital, not the participation of the US
2 mins
January 13, 2026
Mint Hyderabad
Toyota pushes for fuel norm clarity
The government should soon come out with the final notification for the next phase of India’s Corporate Average Fuel Efficiency standards so that the industry can prepare accordingly, according to a senior Toyota Kirloskar Motor executive.
1 min
January 13, 2026
Mint Hyderabad
Food effect lifts Dec CPI inflation
India's retail inflation rose for the second successive month in December, data released by the statistics ministry on Monday showed, driven by a moderation in negative food inflation and an uptick in core inflation.
1 min
January 13, 2026
Mint Hyderabad
Commissions trump advice in wealth management biz
surge on rising affluence, strong economic growth, higher foreign direct investments, and the growth of the startup ecosystem.
2 mins
January 13, 2026
Mint Hyderabad
The Chinese company taking on the world's memory-chip giants
As AI demand drives prices up, CXMT beats Washington's curbs to vie with Micron and South Korean leaders
4 mins
January 13, 2026
Mint Hyderabad
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Hyderabad
Fix GST on capital goods to revive private investment
India faces a paradox today.
3 mins
January 13, 2026
Mint Hyderabad
Feeling tired? It could be too many messages
The cumulative stress of constant notifications is leaving many emotionally burnt out. Tackling it requires small, sustainable changes
4 mins
January 13, 2026
Listen
Translate
Change font size
